BackIsracann Biosciences Overview

Isracann Biosciences Operating Income

Latest operating income for ISCNF: $-2.3M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-306002.00
↓ 40.8% YoY

As of Aug 31, 2022

Annual Operating Income (TTM)

$-2336319.00
↓ 48.9% YoY

Trailing 12 months ending Aug 31, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Isracann Biosciences (ISCNF) FAQ

As of the most recent data (August 2022), ISCNF shows a operating income of $-2.3M. That compares with $-4.6M in the prior-year period — up 48.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ISCNF's operating income is now $-2.3M (was $-4.6M) — a 48.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Isracann Biosciences is outperforming or lagging.

Tracking ISCNF's operating income over time shows whether Isracann Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $-2.3M That compares with $-4.6M in the prior-year period — up 48.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Isracann Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-2.3M) with ownership activity and broader fundamentals.